Cargando…

Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy

BACKGROUND: Gastrointestinal stromal tumour (GIST) is the most common intra-abdominal sarcoma. Risk classification systems, commonly the modified National Institutes of Health consensus criteria, identify tumour properties relating to patient outcomes. However, owing to limited long-term evidence, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berndsen, Marta, Renberg, Sara, Hølmebakk, Toto, Hancke, Emma, Puls, Florian, Karlsson, Fredrik, Stoldt, Stephan, Bjerkehagen, Bodil, Haglund de Flon, Felix, Muth, Andreas, Papakonstantinou, Andri, Boye, Kjetil, Lindskog, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638541/ https://www.ncbi.nlm.nih.gov/pubmed/37758514 http://dx.doi.org/10.1093/bjs/znad309

Ejemplares similares

Diagnosing gastrointestinal stromal tumors: The utility of fine‐needle aspiration cytology versus biopsy
por: Zhang, Yifan, et al.
Publicado: (2022)

The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center
por: Renberg, Sara, et al.
Publicado: (2022)

ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
por: Hølmebakk, Toto, et al.
Publicado: (2021)

Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
por: Gorunova, Ludmila, et al.
Publicado: (2022)

Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
por: Hølmebakk, Toto, et al.
Publicado: (2021)

Defining Tumor Rupture in Gastrointestinal Stromal Tumor
por: Nishida, Toshirou, et al.
Publicado: (2019)

Monitoring Circulating Tumor DNA During Surgical Treatment in Patients with Gastrointestinal Stromal Tumors
por: Johansson, Gustav, et al.
Publicado: (2021)

Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2014)

Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2014)

Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
por: Hompland, Ivar, et al.
Publicado: (2016)

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)

Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumor
por: Tetzlaff, Eric D., et al.
Publicado: (2013)

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
por: Namløs, Heidi M., et al.
Publicado: (2017)

Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs)
por: Åhlén, Jan, et al.
Publicado: (2018)

Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor
por: Ling, Jiayu, et al.
Publicado: (2023)

Novel Fusion of MYST/Esa1-Associated Factor 6 and PHF1 in Endometrial Stromal Sarcoma
por: Panagopoulos, Ioannis, et al.
Publicado: (2012)

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
por: Joensuu, Heikki, et al.
Publicado: (2014)

Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas
por: Zhang, Yifan, et al.
Publicado: (2022)

Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential
por: Namløs, Heidi Maria, et al.
Publicado: (2023)

Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors
por: Fulgenzi, Claudia Angela Maria, et al.
Publicado: (2022)

KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
por: Joensuu, Heikki
Publicado: (2023)

Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study
por: Zhao, Rui, et al.
Publicado: (2017)

Long-term Results of Adjuvant Imatinib Treatment for Localized Gastrointestinal Stromal Tumors after Surgery
por: Aznab, Mozaffar, et al.
Publicado: (2018)

Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor
por: Liu, Xuechao, et al.
Publicado: (2022)

Do Not Be Fooled by Fancy Mutations: Inflammatory Fibroid Polyps Can Harbor Mutations Similar to Those Found in GIST
por: Bjerkehagen, Bodil, et al.
Publicado: (2013)

Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study
por: Qi, Jing, et al.
Publicado: (2020)

Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma
por: Berner, Kjetil, et al.
Publicado: (2015)

Gastrointestinal stromal tumor
por: Stamatakos, Michael, et al.
Publicado: (2009)

Gastrointestinal stromal tumors
por: Beham, Alexander W., et al.
Publicado: (2011)

The “Grep” Command But Not FusionMap, FusionFinder or ChimeraScan Captures the CIC-DUX4 Fusion Gene from Whole Transcriptome Sequencing Data on a Small Round Cell Tumor with t(4;19)(q35;q13)
por: Panagopoulos, Ioannis, et al.
Publicado: (2014)

Fusion of the Genes EWSR1 and PBX3 in Retroperitoneal Leiomyoma with t(9;22)(q33;q12)
por: Panagopoulos, Ioannis, et al.
Publicado: (2015)

Novel KAT6B-KANSL1 Fusion Gene Identified by RNA Sequencing in Retroperitoneal Leiomyoma with t(10;17)(q22;q21)
por: Panagopoulos, Ioannis, et al.
Publicado: (2015)

Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
por: Høland, Maren, et al.
Publicado: (2023)

Gastrointestinal Stromal Tumor: Cause of Gastrointestinal Bleeding
por: Vilallonga, Ramon, et al.
Publicado: (2010)

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)
por: Nilsson, B, et al.
Publicado: (2007)

Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis
por: Jiang, Xuehui, et al.
Publicado: (2023)

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
por: Joensuu, Heikki, et al.
Publicado: (2023)

Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism
por: Théou-Anton, N, et al.
Publicado: (2006)

APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis
por: Stormorken, Astrid Tenden, et al.
Publicado: (2018)

Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
por: Duffy, MJ, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0tk35klvk4p3nhp1ud4m14ubt2